Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytoplasmic dynein 1 light intermediate chain 1 (DYNC1LI1) is a non-catalytic accessory component of the cytoplasmic dynein 1 complex, a large multisubunit motor protein complex responsible for minus-end-directed transport along microtubules. DYNC1LI1 mediates the linking of dynein to cargo and adapter proteins, regulating multiple intracellular transport processes such as vesicle and organelle movement, chromosome segregation during mitosis, and spindle assembly checkpoint progression. The protein is required for the proper transfer of the spindle assembly checkpoint from kinetochores to spindle poles and facilitates endosome recycling and other cell division events through its roles in the cytoplasmic dynein complex[1][5][9]. Note on therapeutic targeting: DYNC1LI1 itself is not a receptor, enzyme, or classical drug target, but a core structural subunit of a microtubule motor; therefore, no direct drugs, mechanisms of action, or clinical biomarkers are listed for this protein as of current knowledge[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytoplasmic dynein 1 light intermediate chain 1 (DYNC1LI1).